- Home
- FBIOP vs USA Comparison
FBIOP vs USA Comparison
Compare FBIOP & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- USA
- Stock Information
- Founded
- FBIOP N/A
- USA 1986
- Country
- FBIOP United States
- USA United States
- Employees
- FBIOP 101
- USA N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- USA Finance Companies
- Sector
- FBIOP Health Care
- USA Finance
- Exchange
- FBIOP Nasdaq
- USA Nasdaq
- Market Cap
- FBIOP N/A
- USA N/A
- IPO Year
- FBIOP N/A
- USA N/A
- Fundamental
- Price
- FBIOP $9.47
- USA $6.74
- Analyst Decision
- FBIOP
- USA
- Analyst Count
- FBIOP 0
- USA 0
- Target Price
- FBIOP N/A
- USA N/A
- AVG Volume (30 Days)
- FBIOP N/A
- USA 880.5K
- Earning Date
- FBIOP N/A
- USA 01-01-0001
- Dividend Yield
- FBIOP N/A
- USA 9.66%
- EPS Growth
- FBIOP N/A
- USA N/A
- EPS
- FBIOP N/A
- USA N/A
- Revenue
- FBIOP N/A
- USA N/A
- Revenue This Year
- FBIOP N/A
- USA N/A
- Revenue Next Year
- FBIOP N/A
- USA N/A
- P/E Ratio
- FBIOP N/A
- USA N/A
- Revenue Growth
- FBIOP N/A
- USA N/A
- 52 Week Low
- FBIOP N/A
- USA $5.62
- 52 Week High
- FBIOP N/A
- USA $7.09
- Technical
- Relative Strength Index (RSI)
- FBIOP 85.14
- USA 61.49
- Support Level
- FBIOP $6.43
- USA $6.56
- Resistance Level
- FBIOP $7.00
- USA $6.69
- Average True Range (ATR)
- FBIOP 0.41
- USA 0.08
- MACD
- FBIOP 0.25
- USA 0.00
- Stochastic Oscillator
- FBIOP 99.37
- USA 95.83
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.